4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-23-001626
Chief Medical Officer sold 60,000 shares at an average $34.82 ($2,089,472)
- Chief Medical Officer acquired 60,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Katz Barrett Chief Medical Officer | 2023-01-09 | Option exercise | +12,623 | $23.03 | $290,708 | 12,623 | D |
| Katz Barrett Chief Medical Officer | 2023-01-09 | Sale | −12,623 | $33.04 | $417,064 | 0 | D |
| Katz Barrett Chief Medical Officer | 2023-01-10 | Option exercise | +47,377 | $23.03 | $1,091,092 | 47,377 | D |
| Katz Barrett Chief Medical Officer | 2023-01-10 | Sale | −47,377 | $35.30 | $1,672,408 | 0 | D |
| Derivatives | |||||||
| Katz Barrett Chief Medical Officer | 2023-01-09 | Option exercise · Stock Option (Right to Buy) | −12,623 | 343,377 | D | ||
| Katz Barrett Chief Medical Officer | 2023-01-10 | Option exercise · Stock Option (Right to Buy) | −47,377 | 296,000 | D | ||
| Open-market sales · 60,000 sh · avg $34.82 · $2,089,472 | |||||||
Loading xslF345X03/doc4.xml…